NCT04472286Completed
Healthy Bones, Healthy Life: Habitual Physical Activity on Bone & Metabolic Health in Pediatric Cancer Survivors
Healthy Bones, Healthy Life: Effect of Habitual Physical Activity on Bone and Metabolic Health in Pediatric Cancer Survivors
Source: ClinicalTrials.gov · Last updated 30 Aug 2024
Brief summary (registry, in English)
This project will examine habitual physical activity, bone health, and insulin resistance in pediatric acute lymphocytic leukemia (ALL) and lymphoma cancer survivors at two time points: baseline and 6 months. At the two study timepoints, all study participants will be asked to wear an accelerometer, receive a DXA scan of the lumbar spine and hip, and have blood drawn for analysis. Study participants will be given a gift card stipend for each study visit attended. Study visits will coincide with regular office visits to Children's Hospital Oncology Clinic and the Children's Hospital Survivorship Clinics whenever possible. The potential mechanism by which physical activity mediates bone changes will be explored by concurrently measuring changes in lean/fat mass and metabolic status. This pilot study will provide data to inform the design of a randomized controlled trial to test the effect of a physical activity intervention on bone health in PCS.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 40 (actual)
- First submitted
- 10 Jul 2020
- Start date
- 1 Nov 2020
- Primary completion date
- 30 May 2024
- Lead sponsor
- University of Nebraska
- NCT number
- NCT04472286
What you commit to
- Study type: Observational
- Participants enrolled: 40
- From 1 Nov 2020 to the primary completion date, 30 May 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Children receiving ongoing cancer treatment
- Children with a prior history of bisphosphonate use or other medication directed at increasing bone density
Other illness
- Children with Down syndrome (identified as a precancerous condition affecting BMD)
Age
- Children younger than 5 years old or 19 or older
Other
- Children without a diagnosis of ALL or lymphoma
Who the study is looking for
- Children between the ages of 5-18
- Diagnosis of ALL or Lymphoma
- Between 1-13 months post-cancer treatment
Age in the registry: 5 years to 18 years · Sex: All
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of Nebraska Medical Center Coordinator of this site? Confirm its status | Omaha | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.